BVMF/M1RN34 (BVMF/M1RN34)

Brazil Stock Exchange: BVMF/M1RN34 · BRL

R$55.8

+2.91 (+5.5%)· Recorded snapshot

Market cap	444B
Revenue (ttm)	11.5B
Net income (ttm)	-16.3B
EPS (ttm)	-R$2.14
Volume	186,412
Beta	1.09

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 11.5B
Net income (ttm): -16.3B
EPS (ttm): -R$2.14
Market cap: 444B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-39

P25 n/aP50 n/aP75 n/a

ROIC-76

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/M1RN34 indicators

Market & fundamental data

Available fields

186

Groups with data

Currency

USD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-06
Employees	4,700
Employees change	-1,100
Employees growth	-18.97%
Enterprise value	BRL 413.9B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2010
Industry	Biotechnology
Is primary listing	No
ISIN number	BRM1RNBDR006
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Last stock split date	2022-11-21
Last stock split type	Forward
Market cap	BRL 444B
Next earnings date	2026-11-06
Price	BRL 55.82
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	bvmf/M1RN34
Website	https://www.modernatx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-3.84%
EV/Sales	34.74x
FCF / EV yield	-1.56%
FCF yield	-1.45%
P/B ratio	12.67x
P/S ratio	38.46x
Price / tangible book value	12.98x
Sector forward P/E	11.27x
Sector P/E	41.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-109.34%
EBITDA margin	-98.52%
Gross margin	-66.02%
Operating margin	-109.34%
Pretax margin	-138.55%
Profit margin	-141.43%
Profit per employee	BRL -3.5M
Revenue per employee	BRL 2.5M
ROA	-13.26%
ROA (5Y)	6.72%
ROCE	-28.91%
ROE	-39%
ROE (5Y)	22.02%
ROIC	-75.99%
ROIC (5Y)	40.43%
SBC / revenue	20.74%
Tax / revenue	2.87%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	2
Net income growth quarters	1
Net income growth years	2
Revenue growth	-27.62%
Revenue growth (Q)	2.11%
Revenue growth (QoQ)	-62.72%
Revenue growth 3Y	-40.64%
Revenue growth 5Y	-20.51%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -885.9M
Depreciation and amortization	BRL 1.3B
EBIT	BRL -12.6B
EBITDA	BRL -11.4B
EPS	BRL -2.14
Financing cash flow	BRL 3.2B
Free cash flow	BRL -6.4B
Free cash flow minus SBC	BRL -8.8B
Gross profit	BRL -7.6B
Income taxes	BRL 331.6M
Investing cash flow	BRL 4.7B
Net borrowing	BRL 3.1B
Net cash flow	BRL 2.3B
Net income	BRL -16.3B
Operating cash flow minus SBC	BRL -8B
Operating income	BRL -12.6B
Revenue	BRL 11.5B
Stock-based compensation	BRL 2.4B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.62
Book value per share	BRL 87.79
Debt / equity	0.19
Goodwill	BRL 278.2M
Interest coverage	-58
Long-term assets	BRL 25.7B
Long-term liabilities	BRL 8.2B
Net cash (debt)	BRL 29.1B
Net cash / market cap	6.56%
Net cash growth	-16.87%
Net debt / equity	-0.83
Piotroski F-Score	2
Property, plant and equipment	BRL 14.7B
Shareholders' equity	BRL 35B
Tangible book value	BRL 34.2B
Tangible book value per share	BRL 85.70
Total assets	BRL 56.8B
Total cash	BRL 26.6B
Total debt	BRL 6.7B
Total liabilities	BRL 21.8B
WACC	10.16%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.19
Current assets	BRL 31.1B
Current liabilities	BRL 13.6B
Current ratio	2.29
Inventory turnover	14.23
Net working capital	BRL -9.4B
Quick ratio	2.07
Working capital	BRL 17B
Working capital turnover	2.93

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.94%
Shareholder yield	-1.94%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 24.23
1D price change	5.5%
1M price change	8.47%
1M total return	8.47%
1W price change	-3.24%
1W total return	-3.24%
1Y price change	658.42%
1Y return CAGR	659.48%
1Y total return	658.42%
20-day SMA	BRL 53.43
200-day SMA	BRL 21.26
3M price change	310.74%
3M total return	310.74%
3Y price change	194.1%
3Y return CAGR	43.26%
3Y total return	194.1%
50-day SMA	BRL 44.43
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 63.81
52-week high date	2026-10-21
52-week low	BRL 6.02
52-week low date	2025-11-21
5Y price change	-41.85%
5Y return CAGR	-10.28%
5Y total return	-41.85%
6M price change	336.09%
6M total return	336.09%
All-time high	BRL 130.62
All-time high date	2021-08-10
All-time low	BRL 6.02
All-time low date	2025-11-21
Average true range (ATR)	BRL 5.56
Average volume	172.9K
Beta (5Y)	1.1
Change from 52-week high	-12.52%
Change from 52-week low	827.24%
Change from all-time high	-57.27%
Change from all-time low	827.24%
Change from open	8.6%
Day's gap	-2.85%
Dollar volume	BRL 10.4M
High price	BRL 55.82
Low price	BRL 47.75
Monthly RSI	78.2
Open price	BRL 51.40
Position in 52-week range	100%
Previous close	BRL 52.91
Price vs 150-day SMA	130.38%
Price vs 20-day SMA	4.48%
Price vs 200-day SMA	162.62%
Price vs 50-day SMA	25.65%
Relative volume	1.08
RSI	56.57
Sharpe ratio	1.61
Sharpe ratio (3Y)	0.61
Sharpe ratio (5Y)	0.25
Sortino ratio	5.73
Sortino ratio (3Y)	1.61
Sortino ratio (5Y)	0.63
Volume	186.4K
Weekly RSI	76.77
YTD price change	567.7%
YTD total return	567.7%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	372M
Shares change (QoQ)	0.76%
Shares change (YoY)	1.94%
Shares held by insiders	6.74%
Shares held by institutions	80.57%
Short ratio	1.6 days

Deeper analysis on BVMF/M1RN34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/M1RN34 report

Is a complete BVMF/M1RN34 research report available?

No complete published report is available for bvmf/M1RN34 (BVMF/M1RN34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/M1RN34 (BVMF/M1RN34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/M1RN34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/M1RN34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/M1RN34

Frequently asked questions